Cytosorbents Corporation Revenue per Employee (CTSO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cytosorbents Corporation  (NASDAQ: CTSO)
 

Cytosorbents's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 9.29% in the second quarter 2026, year on year to cumulative value of $36 million, Cytosorbents's revenue per employee grew on a trailing twelve months basis to $ 276,456. The productivity of Cytosorbents's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 341 other companies have achieved higher revenue per employee. While Cytosorbents's total ranking has deteriorated compared to the previous quarter from 2383 to 2681. Cytosorbents has 129 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CTSO Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 9.29 % -0.95 % 41.55 % -6.63 % -7.25 %
Sales per Employee (TTM) $ 276,456 270,107 270,708 249,696 254,468
CTSO's Total Ranking # 2681 # 2383 # 2417 # 2541 # 2116
Seq. Revenue Change 18.49 % -11.95 % 6.55 % -1.68 % 7.39 %

CTSO Company Profile >> Back to CTSO Efficiency Comparisons >> Compare CTSO Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 108
Healthcare Sector # 342
Overall Market # 2681

Revenue per Employee Statistics
High Average Low
$ 349,809 $ 176,801 $ 10,410
(Jun 30 2021)   (Dec 31 2012)



Financial Statements
Cytosorbents's Revenue MRQ $ 10 Millions Visit CTSO's Income Statement
Cytosorbents's Revenues TTM $ 36 Millions Visit CTSO's aggregate revenue growth
What are CTSO's Sales? Visit CTSO's Sales by Segment




Other Ratios
Cytosorbents's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CTSO's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CTSO's Competitors
Revenue per Employee for CTSO's Suppliers
Revenue per Employee for CTSO's Customers

You may also want to know
CTSO's Sales Growth Rates CTSO's Pe Price to earnings ratio CTSO's Receivables Turnover Ratio CTSO's Stock Quote
CTSO's Net Income Growth Rates CTSO's Ps Price to Sales ratio CTSO's Sales per Employee CTSO's Asset Turnover Ratio
CTSO's Net Margin CTSO's Pb Price to Book ratio CTSO's Financial Strength Ratios CTSO's Dividend Payout Ratio
Date modified: 2026-09-08T17:43:28+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Invivyd Inc   478,401.64 $ 58.365  Million 122 
Maravai Lifesciences Holdings Inc   477,898.85 $ 207.886  Million 435 
Moderna Inc   474,042.55 $ 2,228.000  Million 4,700 
Guardant Health Inc   472,108.94 $ 1,183.105  Million 2,506 
Neuropace Inc   471,866.03 $ 98.620  Million 209 
Skinhealth Systems Inc   471,817.29 $ 289.224  Million 613 
Pelthos Therapeutics Inc   470,695.65 $ 43.304  Million 92 
Inogen Inc   470,523.24 $ 354.304  Million 753 
Regenxbio Inc   470,301.89 $ 174.482  Million 371 
4d Molecular Therapeutics Inc   469,428.57 $ 92.008  Million 196 
Stryker Corp  461,375.00 $ 25,837.000  Million 56,000 
Atara Biotherapeutics Inc   460,857.14 $ 6.452  Million 14 
Glaukos Corp  457,066.73 $ 500.031  Million 1,094 
Treace Medical Concepts Inc   456,237.78 $ 205.307  Million 450 
Medpace Holdings Inc   448,756.13 $ 2,782.288  Million 6,200 
Sight Sciences Inc   448,123.66 $ 83.351  Million 186 
Dexcom Inc   447,639.64 $ 4,968.800  Million 11,100 
Haemonetics Corporation  447,145.88 $ 1,351.722  Million 3,023 
Nakamoto Inc   445,571.28 $ 28.962  Million 65 
Livanova Plc  445,488.48 $ 1,470.112  Million 3,300 
Rockwell Medical inc   444,757.96 $ 69.827  Million 157 
Teladoc Health Inc   444,550.00 $ 2,489.480  Million 5,600 
Trisalus Life Sciences Inc   442,931.37 $ 45.179  Million 102 
Kymera Therapeutics Inc   441,176.47 $ 105.000  Million 238 
Twist Bioscience Corporation  441,060.27 $ 431.798  Million 979 
Natera Inc   440,892.02 $ 2,707.077  Million 6,140 
Electrocore Inc   440,084.34 $ 36.527  Million 83 
Mimedx Group Inc   438,225.25 $ 354.086  Million 808 
Elutia Inc   436,653.85 $ 11.353  Million 26 
Novocure Limited  435,634.27 $ 699.193  Million 1,605 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.